Topical Methotrexate in the Treatment of patches of Hair Fall
- Conditions
- Health Condition 1: L638- Other alopecia areata
- Registration Number
- CTRI/2022/12/048063
- Lead Sponsor
- Vaibhav Vivek Kalgaonkar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of Alopecia Areata of at least 2 months duration
Patients having patches in 1-3 numbers over the scalp.
Patients who are willing to take part in the study with signed and written informed consent.
Patients could be of both male and female.
All patients who are 18 years and above of age
Patient must be medically stable.
Patient must have active mobile number.
Patients who are not willing to sign in after informed consent.
Pregnant, breast feeding, child bearing age using contraception.
Patient with Alopecia Totalis and Alopecia Universalis
Patient with a K/C/O any Autoimmune conditions like SLE, Thyroid disorder, Vitiligo, etc.
Patient receiving systemic treatment relevant to alopecia areata within 3 months of enrollment.
Patient receiving Topical treatment relevant to Alopecia areata within 2 months
Patient with any Fungal infection of scalp
Patient with dermatological conditions affecting skin other than Alopecia Areata.
Patient with psychiatric illness or psychological state interfering with compliance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Observe the Effect of Test Drugs on Hair Regrowth in the patients of Alopecia Areata using Alopecia Grading Scale (AGS) and Alopecia Regrowth Score (RGS). <br/ ><br> <br/ ><br>To compare the efficacy between both the groups <br/ ><br>Timepoint: Baseline on the day of enrollment <br/ ><br>1st,2nd and 3rd month <br/ ><br>
- Secondary Outcome Measures
Name Time Method To check any adverse effects of the the test drugsTimepoint: End of 1st, 2nd and 3rd month